On April 2, Kanec USA Inc. (Davie, FL) issued a voluntary nationwide recall of its dietary supplement called Stud Capsule For Men, after being informed by FDA that laboratory analysis revealed a batch of the product to be adulterated with Sildenafil, an FDA-approved drug used in the treatment of erectile dysfunction. The presence of Sildenafil means that the dietary supplement is misbranded and is actually an unapproved new drug, according to the Federal Food, Drug, and Cosmetic Act.
On April 2, Kanec USA Inc. (Davie, FL) issued a voluntary nationwide recall of its dietary supplement called Stud Capsule For Men, after being informed by FDA that laboratory analysis revealed a batch of the product to be adulterated with Sildenafil, an FDA-approved drug used in the treatment of erectile dysfunction.
The presence of Sildenafil means that the dietary supplement is misbranded and is actually an unapproved new drug, according to the Federal Food, Drug, and Cosmetic Act.
FDA also added that use of the product may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, and heart disease often take nitrates, said FDA, and erectile dysfunction is a common problem in men with these conditions.
Balchem’s Newest Launch Optifolin+® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin+®, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.